In several mouse models of colitis, specific delivery of the protein to the colon provided therapeutic and prophylactic protection.
The authors said their data provide a rationale for development of probiotic-derived proteins as reagents for preventing and treating ulcerative intestinal inflammatory disorders.
Read the Journal of Clinical Investigation abstract on gastrointestinal disorders.
Related Articles on Intestinal Disorders:
Studies Find Dramatic Uptick in Prostate Biopsy Infections
Bacteria in Gut Linked to Brain Chemistry, Behavior
23% of Gastroenterologists Cannot Name Criteria for Diagnosing Barrett’s Esophagus
